These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 36316810

  • 1. Factor D.
    Sekine H, Machida T, Fujita T.
    Immunol Rev; 2023 Jan; 313(1):15-24. PubMed ID: 36316810
    [Abstract] [Full Text] [Related]

  • 2. Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/lpr Mice.
    Machida T, Sakamoto N, Ishida Y, Takahashi M, Fujita T, Sekine H.
    Front Immunol; 2018 Jan; 9():1191. PubMed ID: 29892304
    [Abstract] [Full Text] [Related]

  • 3. Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D.
    Takahashi M, Ishida Y, Iwaki D, Kanno K, Suzuki T, Endo Y, Homma Y, Fujita T.
    J Exp Med; 2010 Jan 18; 207(1):29-37. PubMed ID: 20038603
    [Abstract] [Full Text] [Related]

  • 4. Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement Pathway.
    Hayashi M, Machida T, Ishida Y, Ogata Y, Omori T, Takasumi M, Endo Y, Suzuki T, Sekimata M, Homma Y, Ikawa M, Ohira H, Fujita T, Sekine H.
    J Immunol; 2019 Sep 15; 203(6):1411-1416. PubMed ID: 31399515
    [Abstract] [Full Text] [Related]

  • 5. MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked.
    Dobó J, Szakács D, Oroszlán G, Kortvely E, Kiss B, Boros E, Szász R, Závodszky P, Gál P, Pál G.
    Sci Rep; 2016 Aug 18; 6():31877. PubMed ID: 27535802
    [Abstract] [Full Text] [Related]

  • 6. Key Components of the Complement Lectin Pathway Are Not Only Required for the Development of Inflammatory Arthritis but Also Regulate the Transcription of Factor D.
    Holers VM, Borodovsky A, Scheinman RI, Ho N, Ramirez JR, Dobó J, Gál P, Lindenberger J, Hansen AG, Desai D, Pihl R, Thiel S, Banda NK.
    Front Immunol; 2020 Aug 18; 11():201. PubMed ID: 32153567
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement.
    Banda NK, Takahashi M, Takahashi K, Stahl GL, Hyatt S, Glogowska M, Wiles TA, Endo Y, Fujita T, Holers VM, Arend WP.
    Mol Immunol; 2011 Oct 18; 49(1-2):281-9. PubMed ID: 21943708
    [Abstract] [Full Text] [Related]

  • 8. The complex formation of MASP-3 with pattern recognition molecules of the lectin complement pathway retains MASP-3 in the circulation.
    Kusakari K, Machida T, Ishida Y, Omori T, Suzuki T, Sekimata M, Wada I, Fujita T, Sekine H.
    Front Immunol; 2022 Oct 18; 13():907023. PubMed ID: 36052069
    [Abstract] [Full Text] [Related]

  • 9. Essential role of complement mannose-binding lectin-associated serine proteases-1/3 in the murine collagen antibody-induced model of inflammatory arthritis.
    Banda NK, Takahashi M, Levitt B, Glogowska M, Nicholas J, Takahashi K, Stahl GL, Fujita T, Arend WP, Holers VM.
    J Immunol; 2010 Nov 01; 185(9):5598-606. PubMed ID: 20870940
    [Abstract] [Full Text] [Related]

  • 10. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.
    Ruseva MM, Takahashi M, Fujita T, Pickering MC.
    Clin Exp Immunol; 2014 Apr 01; 176(1):84-92. PubMed ID: 24279761
    [Abstract] [Full Text] [Related]

  • 11. Mannan-Binding Lectin-Associated Serine Protease 1/3 Cleavage of Pro-Factor D into Factor D In Vivo and Attenuation of Collagen Antibody-Induced Arthritis through Their Targeted Inhibition by RNA Interference-Mediated Gene Silencing.
    Banda NK, Acharya S, Scheinman RI, Mehta G, Coulombe M, Takahashi M, Sekine H, Thiel S, Fujita T, Holers VM.
    J Immunol; 2016 Nov 01; 197(9):3680-3694. PubMed ID: 27707997
    [Abstract] [Full Text] [Related]

  • 12. The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway.
    Iwaki D, Kanno K, Takahashi M, Endo Y, Matsushita M, Fujita T.
    J Immunol; 2011 Oct 01; 187(7):3751-8. PubMed ID: 21865552
    [Abstract] [Full Text] [Related]

  • 13. Analysis of Factor D Isoforms in Malpuech-Michels-Mingarelli-Carnevale Patients Highlights the Role of MASP-3 as a Maturase in the Alternative Pathway of Complement.
    Pihl R, Jensen L, Hansen AG, Thøgersen IB, Andres S, Dagnæs-Hansen F, Oexle K, Enghild JJ, Thiel S.
    J Immunol; 2017 Aug 09. PubMed ID: 28794230
    [Abstract] [Full Text] [Related]

  • 14. MASP-1 and MASP-2 Do Not Activate Pro-Factor D in Resting Human Blood, whereas MASP-3 Is a Potential Activator: Kinetic Analysis Involving Specific MASP-1 and MASP-2 Inhibitors.
    Oroszlán G, Kortvely E, Szakács D, Kocsis A, Dammeier S, Zeck A, Ueffing M, Závodszky P, Pál G, Gál P, Dobó J.
    J Immunol; 2016 Jan 15; 196(2):857-65. PubMed ID: 26673137
    [Abstract] [Full Text] [Related]

  • 15. Deconstructing the Lectin Pathway in the Pathogenesis of Experimental Inflammatory Arthritis: Essential Role of the Lectin Ficolin B and Mannose-Binding Protein-Associated Serine Protease 2.
    Banda NK, Acharya S, Scheinman RI, Mehta G, Takahashi M, Endo Y, Zhou W, Farrar CA, Sacks SH, Fujita T, Sekine H, Holers VM.
    J Immunol; 2017 Sep 01; 199(5):1835-1845. PubMed ID: 28739878
    [Abstract] [Full Text] [Related]

  • 16. The role of MASP-1/3 in complement activation.
    Sekine H, Takahashi M, Iwaki D, Fujita T.
    Adv Exp Med Biol; 2013 Sep 01; 735():41-53. PubMed ID: 23402018
    [Abstract] [Full Text] [Related]

  • 17. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway.
    Takahashi M, Iwaki D, Kanno K, Ishida Y, Xiong J, Matsushita M, Endo Y, Miura S, Ishii N, Sugamura K, Fujita T.
    J Immunol; 2008 May 01; 180(9):6132-8. PubMed ID: 18424734
    [Abstract] [Full Text] [Related]

  • 18. MASP3 Deficiency in Mice Reduces but Does Not Abrogate Alternative Pathway Complement Activity Due to Intrinsic Profactor D Activity.
    Gullipalli D, Miwa T, Golla M, Sato S, Angampalli S, Song WC.
    J Immunol; 2023 May 15; 210(10):1543-1551. PubMed ID: 36988282
    [Abstract] [Full Text] [Related]

  • 19. Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases.
    Dobó J, Kocsis A, Gál P.
    Front Immunol; 2018 May 15; 9():1851. PubMed ID: 30135690
    [Abstract] [Full Text] [Related]

  • 20. Proprotein Convertase Is the Highest-Level Activator of the Alternative Complement Pathway in the Blood.
    Oroszlán G, Dani R, Végh BM, Varga D, Ács AV, Pál G, Závodszky P, Farkas H, Gál P, Dobó J.
    J Immunol; 2021 May 01; 206(9):2198-2205. PubMed ID: 33858964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.